Calidi BiotherapeuticsCLDI
13F holders, Q3 2025 (September 30)22holders
$1.52avg. 13F price*
At the end of Q3 2025, 22 institutions reported holding Calidi Biotherapeutics Inc. (CLDI) in their 13F filings. The largest holders were HighTower Advisors, LLC ($129K), Vanguard Group Inc. ($53K) and Geode Capital Management, LLC ($45K).
- Company
- Calidi Biotherapeutics Inc.
- CUSIP
- 320703408
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 22 | $322K |
| Exits | 0 | $0 |
Ownership 22 holders
| HighTower Advisors, LLC | 0.00% | New | 84,956 | $129K |
| Vanguard Group Inc. | 0.00% | New | 34,728 | $53K |
| Geode Capital Management, LLC | 0.00% | New | 29,595 | $45K |
| Belpointe Asset Management LLC | 0.00% | New | 20,821 | $32K |
| Warberg Asset Management LLC | 0.10% | New | 18,705 | $28K |
| RS Crum Inc. | 0.01% | New | 15,256 | $23K |
| UBS Group AG | 0.00% | New | 2,564 | $4K |
| Finepoint Capital LP | 0.00% | New | 1,042 | $2K |
| Highbridge Capital Management LLC | 0.00% | New | 1,042 | $2K |
| Apollo Management Holdings, L.P. | 0.00% | New | 1,042 | $2K |
| Royal Bank of Canada | 0.00% | New | 417 | $1K |
| Morgan Stanley | 0.00% | New | 387 | $588 |
| Barrett & Company, Inc. | 0.00% | New | 292 | $444 |
| Osaic Holdings, Inc. | 0.00% | New | 147 | $228 |
| FMR LLC | 0.00% | New | 125 | $190 |
| Tradewinds Capital Management, LLC | 0.00% | New | 101 | $154 |
| Reyes Financial Architecture, Inc. | 0.00% | New | 100 | $152 |
| SBI Securities Co., Ltd. | 0.00% | New | 46 | $70 |
| CVA Family Office, LLC | 0.00% | New | 42 | $64 |
| Bank of America Corp. | 0.00% | New | 30 | $46 |
| JPMorgan Chase & Co. | 0.00% | New | 9 | $14 |
| Evermay Wealth Management LLC | 0.00% | New | 1 | $2 |
"% of holder's portfolio" is CLDI's weight in each manager's 13F, not the share of Calidi Biotherapeutics Inc. the manager owns.